Good analysis @scottm.I think there is definitely a picture with...

First 5 Last

Share
Profile

Follow
coinflipper

104 Posts.

17

20/03/24

13:31

Post #: 72977014
Share

Originally posted by scottm: ↑

My take from the presentation

- looking at a tungsten deficit coming. Should be good for tungsten price?
- having multiple mines positions us as the largest non-Chinese, except for Masan (a strategic partner).
- emphasis again on vertical intergation and other mines in area.
- "elaborating opportunities for downstream processing through acquisition or strategic partnerships". & "value add through refinery supply is logical next step as significant supplier of concentrates outside of China". "Ability to become the largest (integrated) supplier to end users outside of China".
Curious what these statements mean. We refine the tungsten with Masan. Olli met the Vietnam PM last week. Is a deal coming with Masan?
- "Potential partnerships, structures and options being explored". Something is brewing! given slide shows additional asset?
- Ferro-tungsten production - better price, more $$.
- Nearly 1000t 50% production for quarter. That would be around 500t Mt Carbine, 450t Saloro. I would think that's not far from breakeven cashflow. Their aim is to get to 3000t to 5000t of WO3 per year. This suggests lots of upside.
- More expansion at Mt Carbine with crushing
- Saloro improvements being found with the ore sorters and Kevin's recent visit.
- More room to expand at existing and others.

In short more new flow expected. This company has got a global big picture in mind.

Expand

Good analysis @scottm.

I think there is definitely a picture with Masan in it somewhere...

EQR Price at posting: 5.1¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

OJC

SPC to merge with Original Juice Co and Nature One Dairy

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 43 more messages in this thread...

First 5 Last

Add EQR (ASX) to my watchlist

(20min delay)
Last 5.3¢		Change 0.003(6.00%)		Mkt cap ! $118.5M

Open	High	Low	Value	Volume
5.2¢	5.3¢	5.1¢	$49.65K	950.7K

Buyers (Bids)

No.	Vol.	Price($)
2	174126	5.2¢

Sellers (Offers)

Price($)	Vol.	No.
5.4¢	50000	1

View Market Depth

No.	Vol.	Price($)
2	174126	0.052
5	340143	0.050
2	220000	0.049
2	58229	0.048
1	133603	0.047

Price($)	Vol.	No.
0.054	50000	1
0.055	600000	2
0.058	750000	1
0.059	740000	1
0.060	10000	1

Last trade - 15.01pm 02/10/2024 (20 minute delay)

EQR (ASX) Chart

Good analysis @scottm.I think there is definitely a picture with...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Good analysis @scottm.I think there is definitely a picture with...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News